by lythamcorp | Nov 8, 2024 | Healthcare, Kiora News, Kiora Pharmaceuticals
Encinitas, California–(November 8, 2024) – Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (“Kiora” or the “Company”) today announced third quarter 2024 financial results and provided an update on its pipeline of therapeutics for the...
by lythamcorp | Nov 7, 2024 | Industrials, LiqTech, LiqTech News
Management to Host Conference Call on Thursday, November 14, 2024, at 9:00 a.m. ET BALLERUP, Denmark, Nov. 7, 2024 — LiqTech International, Inc. (NASDAQ: LIQT), a high-tech filtration company that manufactures and markets highly specialized filtration products...
by lythamcorp | Nov 7, 2024 | Industrials, LiqTech, LiqTech News
BALLERUP, Denmark, Nov. 7, 2024 — LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company that manufactures and markets highly specialized filtration products and systems, and Jiangsu Marine Equipment Co., Ltd. (“JiTRI”), have...
by lythamcorp | Nov 7, 2024 | Cadrenal Therapeutics, Cadrenal Therapeutics News, Healthcare
PONTE VEDRA, Fla., Nov. 7, 2024 — Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) (the “Company” or “Cadrenal”), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer and...
by lythamcorp | Nov 7, 2024 | ChromaDex News, Consumer
National rollout provides enhanced accessibility to Niagen IV, a significant advancement in NAD+ IV therapy LOS ANGELES – ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging,...